StockData
LFVNNasdaqPharmaceutical PreparationsFiscal year ends December 31

Lifevantage Corp

Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Aug 27, 2026
$5.98−0.02 (-0.33%)

Close on Oct 19, 2026

Market cap
$74.97M
P/E (TTM)
15.0
Dividend yield
3.09%

Lifevantage Corp balance sheet

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
77.6%
Operating margin
3.3%
Net margin
2.8%
Return on equity, FY2026
14.9%

Financial strength

Current ratio
1.89
Debt to equity
–
Debt to assets
–
Cash to current liabilities
73.8%

Valuation

P/E ratio
15.0
Price to sales
0.41
Price to book
2.23
Dividend yield
3.09%